Related Experiment Video

Updated: Jul 14, 2026

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

Depression and ischemic heart disease: what have we learned from clinical trials?

Sarah Rivelli1, Wei Jiang

  • 1Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA.

Current Opinion in Cardiology
|June 9, 2007
PubMed

Insights

Depression significantly impacts patients with ischemic heart disease (IHD), increasing mortality and cardiovascular events, especially in women. While some antidepressants show promise, more research is needed to confirm if treating depression improves IHD outcomes.

Area of Science:

  • Cardiology
  • Psychiatry
  • Clinical Medicine

Background:

  • Depression is highly prevalent in patients with ischemic heart disease (IHD).
  • Depression independently predicts a poor prognosis in IHD patients, comparable to traditional cardiac risk factors.

Purpose of the Study:

  • To discuss the complex relationship between depression and ischemic heart disease.
  • To review the impact of depression on IHD prognosis and the efficacy of various treatments.

Main Methods:

  • Review of studies examining depression prevalence in IHD patients.
  • Analysis of research on the impact of depression on cardiovascular outcomes.
  • Evaluation of pharmacological and psychological interventions for depression in IHD.

Main Results:

  • Depression significantly increases mortality and cardiovascular events, particularly in women with IHD.
  • Sertraline and citalopram are safe and effective for depression in IHD patients; mirtazapine showed limited efficacy post-myocardial infarction.
  • Cognitive-behavioral and interpersonal therapies demonstrated no significant treatment effect.

Conclusions:

  • Approximately 25-30% of IHD patients experience depression.
  • Effective treatment of depression may enhance the prognosis for IHD patients.
  • Further research with adequate statistical power is required to fully ascertain the cardiovascular benefits of depression interventions in IHD.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...